Filing Details

Accession Number:
0001181431-11-054340
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-02 16:41:18
Reporting Period:
2011-10-31
Filing Date:
2011-11-02
Accepted Time:
2011-11-02 16:41:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378166 David Young 6011 University Blvd.
Suite 260
Ellicott City MD 21043
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-31 75,000 $4.54 83,002 No 4 M Direct
Common Stock Disposition 2011-10-31 75,000 $41.03 8,002 No 4 S Direct
Common Stock Disposition 2011-10-31 4,724 $41.40 3,278 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-10-31 75,000 $0.00 75,000 $4.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
275,000 2019-10-29 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.79-$41.53, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40-$41.43, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 2 of the Form 4.
  3. Non-Qualified Stock option granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on October 30, 2009.
  4. Of the total amount of shares underlying the option, 175,000 were vested and exercisable as of Octboer 30, 2011.